Parasitological and immunological follow-up of American tegumentary leishmaniasis patients

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue SUPPL. 1, 2002, Pages S173-

  Coutinho, Sergio G ^a,b   Pirmez, Claude ^a   Da Cruz, Alda Maria ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Departamento De Imunologia   (Brazil)

Author keywords

Brazil; Cytokines; Evaluation of cure; Leishmania braziliensis; Leishmaniasis; Polymerase chain reaction; T cells

Indexed keywords

ANTIPROTOZOAL AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; GAMMA INTERFERON; OLIGONUCLEOTIDE; PARASITE ANTIGEN; PROTOZOAL DNA;

ANAMNESIS; ANTIGEN SPECIFICITY; BRAZIL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DNA ISOLATION; ENDEMIC DISEASE; EVALUATION; FOLLOW UP; HEALING; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IN VITRO STUDY; LEISHMANIA BRAZILIENSIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; PARASITOLOGY; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; REINFECTION; RELAPSE; REVIEW; SKIN LEISHMANIASIS; SKIN TEST; T LYMPHOCYTE; ANIMAL; ARTICLE; ISOLATION AND PURIFICATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

LEISHMANIA BRAZILIENSIS;

ANIMALS; DNA, PROTOZOAN; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 0036330885     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-9203(02)90072-6     Document Type: Review

References (51)

1. Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction
2. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis - A possible hazard for the host
3. Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement
4. Leishmania and human immunodeficiency virus coinfection: The first 10 years
5. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease
6. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection
7. Lymph node involvement in leishmaniasis
8. American mucocutaneous leishmaniasis. Culture of Leishmania species from peripheral blood leukocytes
9. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis
10. Cell mediated immunity in American cutaneous and mucosal leishmaniasis
11. Characterization of the cellular immune response in American cutaneous leishmaniasis
12. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis
13. Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis
14. +T cell immune responses of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis
15. T cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: Immunologic patterns associated with cure
16. Failure to detect circulating Leishmania in mucocutaneous leishmaniasis due to Leishmania braziliensis braziliensis
17. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS
18. + T cells associated with cure of human cutaneous leishmaniasis
19. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis
20. Analysis of antigen-reactive T cells derived from lesions of American tegumentary leishmaniasis patients
21. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis
22. Use of molecular probes and PCR for detection and typing of Leishmania - A mini-review
23. Leishmania infantum tropism: Strain genotype or host immune status?
24. A review of the geographic distribution and epidemiology of leishmaniasis in the New World
25. Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy
26. On T cell memory: Arguments for antigen dependence
27. The American leishmaniases: Some observations on their ecology and epidemiology
28. Early parasite containment is decisive for resistance to Leishmania major infection
29. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: Re-examination of haematogenous dissemination
30. Human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in Brazil: Lymphoproliferative responses and influence of therapy
31. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis
32. Experiences with vaccines against cutaneous leishmaniasis: Of men and mice
33. Lymphocytes bearing antigen-specific γδ T cell receptors accumulate in human infectious disease
34. Hallazgo de ADN de leishmaniasis en monocitos de sangre periférica de pacientes y de personas sanas prodedentes de zonas endémicas de leishmaniasis mediante la reacción en cadena de polimerasa
35. American tegumentary leishmaniasis (ATL) in Rio de Janeiro state, Brazil: Main clinical and epidemiologic characteristics
36. Occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors
37. Immunologic responsiveness in American cutaneous leishmaniasis lesions
38. Cytokine patterns in the pathogenesis of human leishmaniasis
39. Hematogenic dissemination, parasite persistence and immune evasion in human leishmaniasis
40. Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil
41. Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection
42. Leishmania mexicana amazonensis infections in resistant inbred mice following removal of the draining lymph node
43. Is leishmaniasis ever cured?
44. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis
45. Detection of Leishmania DNA by the polymerase chain reaction in scars of treated human patients
46. Cutaneous scars in American tegumentary leishmaniasis patients: A site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure
47. Sensitivity of the culture of circulating leukocytes in the detection of Leishmania in the peripheral blood of patients with tegumentary leishmaniasis
48. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients
49. Bubonic leishmaniasis: A common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil
50. Leishmaniose con localizzazione nella cavita mucose (nuova forma clinica)